Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach
- PMID: 36224441
- DOI: 10.1007/s12032-022-01854-1
Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach
Abstract
The precise mechanism of action of Janus Kinases (JAK)/Signal Transducer and activator of Transcription (STAT) signaling in human papillomavirus (HPV)-associated cervical cancer (CaCx) is poorly defined. The present study dissected the underlying components of JAK/STAT signaling in HPV-positive cervical neoplasms. Whole transcriptome profile of CaCx cohort from TCGA database revealed elevated STAT3 and its impact on CaCx patients' survival. Using the RT2 Profiler PCR Array, we analyzed 84 genes of interest associated with JAK/STAT signaling in mRNA derived from HPV-negative and HPV-positive cervical lesions which revealed 21 differentially expressed genes (DEGs). Analyses of DEGs using the Database for Annotation, Visualization and Integrated Discovery tool indicated maximum genes enriched in immune response and negative regulation of apoptotic process. Protein-protein network analysis indicated IL4, STAT5A, STAT4, and JAK3 to be the key genes in the interaction network. Further, 7 key DEGs (IL4R, IRF1, EGFR, OAS1, PIAS1, STAT4, and STAT5A) were validated in TCGA cohort using R2 platform. These genes were differentially expressed among HPV-positive cervical tissues and their correlation with STAT3 was established. EGFR and IL4R showed a comparatively strong correlation with STAT3 that supports their involvement in pathogenesis of CaCx. Finally, the Kaplan-Meier analysis established the prognostic association of the key DEGs, in CaCx cohort. The STAT3 and associated key genes discovered from our study establish a strong pathogenic role of JAK/STAT3 pathway in HPV-mediated cervical carcinogenesis.
Keywords: Cervical cancer (CaCx); Differentially expressed genes (DEGs); Human papillomavirus (HPV); Janus Kinases (JAK)/Signal Transducer and activator of Transcription (STAT) pathway.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.Crit Rev Oncol Hematol. 2024 May;197:104346. doi: 10.1016/j.critrevonc.2024.104346. Epub 2024 Apr 10. Crit Rev Oncol Hematol. 2024. PMID: 38608913 Review.
-
Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.Cells. 2020 Oct 15;9(10):2297. doi: 10.3390/cells9102297. Cells. 2020. PMID: 33076315 Free PMC article. Review.
-
Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control.Biochim Biophys Acta Mol Basis Dis. 2023 Dec;1869(8):166817. doi: 10.1016/j.bbadis.2023.166817. Epub 2023 Jul 31. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 37532113
-
JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.Genes (Basel). 2023 May 24;14(6):1141. doi: 10.3390/genes14061141. Genes (Basel). 2023. PMID: 37372319 Free PMC article. Review.
-
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.Viruses. 2020 Sep 3;12(9):977. doi: 10.3390/v12090977. Viruses. 2020. PMID: 32899142 Free PMC article. Review.
Cited by
-
E5 Oncoprotein: A Key Player in Human Papillomavirus-Positive Head and Neck Cancer Pathogenesis and Therapy Resistance.Viruses. 2025 Apr 1;17(4):512. doi: 10.3390/v17040512. Viruses. 2025. PMID: 40284955 Free PMC article. Review.
-
Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.BMC Cancer. 2023 Jul 20;23(1):684. doi: 10.1186/s12885-023-11163-z. BMC Cancer. 2023. PMID: 37474926 Free PMC article.
-
The AXL-mediated modulation of myeloid-derived suppressor cells (MDSC) in nasopharyngeal carcinoma.Med Oncol. 2024 Nov 27;42(1):17. doi: 10.1007/s12032-024-02561-9. Med Oncol. 2024. PMID: 39592496
References
-
- WHO Organization. Global Cancer Observatory. 2020. https://gco.iarc.fr/ .
-
- Blodt S, Holmberg C, Muller-Nordhorn J, Rieckmann N. Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18–25 year old male and female vocational school students in Berlin, Germany. Eur J Public Health. 2012;22:808–13. https://doi.org/10.1093/eurpub/ckr188 . - DOI - PubMed
-
- Pappa KI, Lygirou V, Kontostathi G, Zoidakis J, Makridakis M, Vougas K, Daskalakis G, Polyzos A, Anagnou NP. Proteomic analysis of normal and cancer cervical cell lines reveals deregulation of cytoskeleton-associated proteins. Cancer Genom Proteom. 2017;14:253–66. https://doi.org/10.21873/cgp.20036 . - DOI
-
- McBride AA. The papillomavirus E2 proteins. Virology. 2013;445:57–79. https://doi.org/10.1016/j.virol.2013.06.006 . - DOI - PubMed
-
- Bechtold V, Beard P, Raj K. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol. 2003;77:2021–8. https://doi.org/10.1128/jvi.77.3.2021-2028.2003 . - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous